Quantitation of coeliac toxicity in wheat using genomics and proteomics

Research output: Chapter in Book/Report/Conference proceedingConference paperAcademicpeer-review

Abstract

Several tests are currently marketed for measuring the amount of gluten in food products and to determine whether products are gluten-free. Of these tests, the Codex Alimentarius approved the R-Biopharm R5 ELISA as the gluten detection standard. This test is based on recognition by a monoclonal antibody (mAb) of five amino acidlong peptide sequences, which are abundantly present in the gliadin proteins of wheat gluten. Another mAb-based test recognises specific peptide sequences of six amino acids (G12 ELISA, Romer Labs). Both tests enable estimating the total amount of gluten (gluten = gliadin x 2) in a wheat product. As the number and composition of coeliac disease (CD) epitopes vary between gliadins and glutenins, among varieties, and between wheat, rye and barley, there is no direct relationship between the estimated gluten content and the presence of CD epitopes. Many research groups have raised epitope-specific T cell clones (TCCs) from patient biopsies that can be used for detection of specific CD-immunogenic gluten epitopes. Such CD epitopes are specific nine amino acid-long peptide sequences rich in prolamin (P) and glutamin (Q) residues. Recently, a list of internationally agreed CD epitopes has been published [1]. Unfortunately, T cell-based tests are mostly qualitative, indicating the presence or absence of a particular epitope, and they are unable to quantitate the overall CD-immunogencity of a given wheat variety. Proper quantitation of CD epitopes is relevant because the amount of non-CDimmunogenic gluten proteins can differ among wheat varieties and genomes (ploidy levels) [2], and the CD-immunogenicity of individual epitopes can be different according to the patient’s sensitivity profile [3,4]. Already a single amino acid substitution in a T cell epitope, especially from proline (P) to serine (S), may abolish T cell binding and thus eliminate the epitope’s CD-immunogenicity [5]. Therefore, gluten detection in the context of coeliac disease should be in line with the internationally agreed list of CD-relevant epitopes. To overcome the shortcomings of mAb-based and T cell-based tests, new approaches are now under development, especially based on genomic and proteomic analysis, aiming at the identification of the profile of CD-immunogenic epitopes of individual wheat species and varieties (for breeding and selection), and at quantitation of CD epitope-containing gluten proteins or fragments in foods (for food diagnostics).
Original languageEnglish
Title of host publicationProceedings of the 27th meeting of the working group on prolamin analysis and toxicity
EditorsP. Koehler
Pages45-51
Publication statusPublished - 2013
EventThe 27th meeting of the working group on prolamin analysis and toxicity, Darmstadt, Germany -
Duration: 10 Oct 201312 Oct 2013

Conference

ConferenceThe 27th meeting of the working group on prolamin analysis and toxicity, Darmstadt, Germany
Period10/10/1312/10/13

Fingerprint

celiac disease
abdomen
proteomics
epitopes
gluten
toxicity
genomics
wheat
T-lymphocytes
gliadin
testing
monoclonal antibodies
peptides
immune response
enzyme-linked immunosorbent assay
wheat products
Codex Alimentarius
amino acids
wheat gluten
proteins

Cite this

Gilissen, L. J. W. J., Salentijn, E. M. J., van den Broeck, H. C., Cordewener, J. H. G., America, T. H. P., Schaart, J. G., ... Smulders, M. J. M. (2013). Quantitation of coeliac toxicity in wheat using genomics and proteomics. In P. Koehler (Ed.), Proceedings of the 27th meeting of the working group on prolamin analysis and toxicity (pp. 45-51)
Gilissen, L.J.W.J. ; Salentijn, E.M.J. ; van den Broeck, H.C. ; Cordewener, J.H.G. ; America, T.H.P. ; Schaart, J.G. ; van der Meer, I.M. ; Smulders, M.J.M. / Quantitation of coeliac toxicity in wheat using genomics and proteomics. Proceedings of the 27th meeting of the working group on prolamin analysis and toxicity. editor / P. Koehler. 2013. pp. 45-51
@inproceedings{414f65a18fc34f02beac025084f31389,
title = "Quantitation of coeliac toxicity in wheat using genomics and proteomics",
abstract = "Several tests are currently marketed for measuring the amount of gluten in food products and to determine whether products are gluten-free. Of these tests, the Codex Alimentarius approved the R-Biopharm R5 ELISA as the gluten detection standard. This test is based on recognition by a monoclonal antibody (mAb) of five amino acidlong peptide sequences, which are abundantly present in the gliadin proteins of wheat gluten. Another mAb-based test recognises specific peptide sequences of six amino acids (G12 ELISA, Romer Labs). Both tests enable estimating the total amount of gluten (gluten = gliadin x 2) in a wheat product. As the number and composition of coeliac disease (CD) epitopes vary between gliadins and glutenins, among varieties, and between wheat, rye and barley, there is no direct relationship between the estimated gluten content and the presence of CD epitopes. Many research groups have raised epitope-specific T cell clones (TCCs) from patient biopsies that can be used for detection of specific CD-immunogenic gluten epitopes. Such CD epitopes are specific nine amino acid-long peptide sequences rich in prolamin (P) and glutamin (Q) residues. Recently, a list of internationally agreed CD epitopes has been published [1]. Unfortunately, T cell-based tests are mostly qualitative, indicating the presence or absence of a particular epitope, and they are unable to quantitate the overall CD-immunogencity of a given wheat variety. Proper quantitation of CD epitopes is relevant because the amount of non-CDimmunogenic gluten proteins can differ among wheat varieties and genomes (ploidy levels) [2], and the CD-immunogenicity of individual epitopes can be different according to the patient’s sensitivity profile [3,4]. Already a single amino acid substitution in a T cell epitope, especially from proline (P) to serine (S), may abolish T cell binding and thus eliminate the epitope’s CD-immunogenicity [5]. Therefore, gluten detection in the context of coeliac disease should be in line with the internationally agreed list of CD-relevant epitopes. To overcome the shortcomings of mAb-based and T cell-based tests, new approaches are now under development, especially based on genomic and proteomic analysis, aiming at the identification of the profile of CD-immunogenic epitopes of individual wheat species and varieties (for breeding and selection), and at quantitation of CD epitope-containing gluten proteins or fragments in foods (for food diagnostics).",
author = "L.J.W.J. Gilissen and E.M.J. Salentijn and {van den Broeck}, H.C. and J.H.G. Cordewener and T.H.P. America and J.G. Schaart and {van der Meer}, I.M. and M.J.M. Smulders",
note = "This research was funded by the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK03009), and by the DLO program ‘Plant and Animal for Human Health’ (KB-05-001-019; KB-15-001-007)",
year = "2013",
language = "English",
isbn = "9783938896785",
pages = "45--51",
editor = "P. Koehler",
booktitle = "Proceedings of the 27th meeting of the working group on prolamin analysis and toxicity",

}

Gilissen, LJWJ, Salentijn, EMJ, van den Broeck, HC, Cordewener, JHG, America, THP, Schaart, JG, van der Meer, IM & Smulders, MJM 2013, Quantitation of coeliac toxicity in wheat using genomics and proteomics. in P Koehler (ed.), Proceedings of the 27th meeting of the working group on prolamin analysis and toxicity. pp. 45-51, The 27th meeting of the working group on prolamin analysis and toxicity, Darmstadt, Germany, 10/10/13.

Quantitation of coeliac toxicity in wheat using genomics and proteomics. / Gilissen, L.J.W.J.; Salentijn, E.M.J.; van den Broeck, H.C.; Cordewener, J.H.G.; America, T.H.P.; Schaart, J.G.; van der Meer, I.M.; Smulders, M.J.M.

Proceedings of the 27th meeting of the working group on prolamin analysis and toxicity. ed. / P. Koehler. 2013. p. 45-51.

Research output: Chapter in Book/Report/Conference proceedingConference paperAcademicpeer-review

TY - GEN

T1 - Quantitation of coeliac toxicity in wheat using genomics and proteomics

AU - Gilissen, L.J.W.J.

AU - Salentijn, E.M.J.

AU - van den Broeck, H.C.

AU - Cordewener, J.H.G.

AU - America, T.H.P.

AU - Schaart, J.G.

AU - van der Meer, I.M.

AU - Smulders, M.J.M.

N1 - This research was funded by the Coeliac Disease Consortium, an Innovative Cluster approved by the Netherlands Genomics Initiative and partially funded by the Dutch Government (BSIK03009), and by the DLO program ‘Plant and Animal for Human Health’ (KB-05-001-019; KB-15-001-007)

PY - 2013

Y1 - 2013

N2 - Several tests are currently marketed for measuring the amount of gluten in food products and to determine whether products are gluten-free. Of these tests, the Codex Alimentarius approved the R-Biopharm R5 ELISA as the gluten detection standard. This test is based on recognition by a monoclonal antibody (mAb) of five amino acidlong peptide sequences, which are abundantly present in the gliadin proteins of wheat gluten. Another mAb-based test recognises specific peptide sequences of six amino acids (G12 ELISA, Romer Labs). Both tests enable estimating the total amount of gluten (gluten = gliadin x 2) in a wheat product. As the number and composition of coeliac disease (CD) epitopes vary between gliadins and glutenins, among varieties, and between wheat, rye and barley, there is no direct relationship between the estimated gluten content and the presence of CD epitopes. Many research groups have raised epitope-specific T cell clones (TCCs) from patient biopsies that can be used for detection of specific CD-immunogenic gluten epitopes. Such CD epitopes are specific nine amino acid-long peptide sequences rich in prolamin (P) and glutamin (Q) residues. Recently, a list of internationally agreed CD epitopes has been published [1]. Unfortunately, T cell-based tests are mostly qualitative, indicating the presence or absence of a particular epitope, and they are unable to quantitate the overall CD-immunogencity of a given wheat variety. Proper quantitation of CD epitopes is relevant because the amount of non-CDimmunogenic gluten proteins can differ among wheat varieties and genomes (ploidy levels) [2], and the CD-immunogenicity of individual epitopes can be different according to the patient’s sensitivity profile [3,4]. Already a single amino acid substitution in a T cell epitope, especially from proline (P) to serine (S), may abolish T cell binding and thus eliminate the epitope’s CD-immunogenicity [5]. Therefore, gluten detection in the context of coeliac disease should be in line with the internationally agreed list of CD-relevant epitopes. To overcome the shortcomings of mAb-based and T cell-based tests, new approaches are now under development, especially based on genomic and proteomic analysis, aiming at the identification of the profile of CD-immunogenic epitopes of individual wheat species and varieties (for breeding and selection), and at quantitation of CD epitope-containing gluten proteins or fragments in foods (for food diagnostics).

AB - Several tests are currently marketed for measuring the amount of gluten in food products and to determine whether products are gluten-free. Of these tests, the Codex Alimentarius approved the R-Biopharm R5 ELISA as the gluten detection standard. This test is based on recognition by a monoclonal antibody (mAb) of five amino acidlong peptide sequences, which are abundantly present in the gliadin proteins of wheat gluten. Another mAb-based test recognises specific peptide sequences of six amino acids (G12 ELISA, Romer Labs). Both tests enable estimating the total amount of gluten (gluten = gliadin x 2) in a wheat product. As the number and composition of coeliac disease (CD) epitopes vary between gliadins and glutenins, among varieties, and between wheat, rye and barley, there is no direct relationship between the estimated gluten content and the presence of CD epitopes. Many research groups have raised epitope-specific T cell clones (TCCs) from patient biopsies that can be used for detection of specific CD-immunogenic gluten epitopes. Such CD epitopes are specific nine amino acid-long peptide sequences rich in prolamin (P) and glutamin (Q) residues. Recently, a list of internationally agreed CD epitopes has been published [1]. Unfortunately, T cell-based tests are mostly qualitative, indicating the presence or absence of a particular epitope, and they are unable to quantitate the overall CD-immunogencity of a given wheat variety. Proper quantitation of CD epitopes is relevant because the amount of non-CDimmunogenic gluten proteins can differ among wheat varieties and genomes (ploidy levels) [2], and the CD-immunogenicity of individual epitopes can be different according to the patient’s sensitivity profile [3,4]. Already a single amino acid substitution in a T cell epitope, especially from proline (P) to serine (S), may abolish T cell binding and thus eliminate the epitope’s CD-immunogenicity [5]. Therefore, gluten detection in the context of coeliac disease should be in line with the internationally agreed list of CD-relevant epitopes. To overcome the shortcomings of mAb-based and T cell-based tests, new approaches are now under development, especially based on genomic and proteomic analysis, aiming at the identification of the profile of CD-immunogenic epitopes of individual wheat species and varieties (for breeding and selection), and at quantitation of CD epitope-containing gluten proteins or fragments in foods (for food diagnostics).

M3 - Conference paper

SN - 9783938896785

SP - 45

EP - 51

BT - Proceedings of the 27th meeting of the working group on prolamin analysis and toxicity

A2 - Koehler, P.

ER -

Gilissen LJWJ, Salentijn EMJ, van den Broeck HC, Cordewener JHG, America THP, Schaart JG et al. Quantitation of coeliac toxicity in wheat using genomics and proteomics. In Koehler P, editor, Proceedings of the 27th meeting of the working group on prolamin analysis and toxicity. 2013. p. 45-51